author-photo

Steinar Aamdal

Oslo University Hospital
University of Oslo

172

Papers

6832

Citations

Citation Trend

Filter By

Papers (131) Sort By

Journal Conference Others

Long-term first-in-man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high-risk prostate cancer after radical prostatectomy.

2021 The Prostate
Show All
- Source
- Cite
- Save
Citations (0)
Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

2021 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (0)
382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma

2021 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer

2020 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (5)
The tyrosine kinase inhibitor crizotinib does not have clinically meaningful activity in heavily pre-treated patients with advanced alveolar rhabdomyosarcoma with FOXO rearrangement: European Organisation for Research and Treatment of Cancer phase 2 trial 90101 ‘CREATE’

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (21)
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

2018 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (39)
Abstract 5713: Promising predictive biomarkers for immunotherapy in metastatic melanoma

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Acute liver graft rejection after ipilimumab therapy

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (21)
T-helper cell receptors from long-term survivors after telomerase cancer vaccination for use in adoptive cell therapy

2016 OncoImmunology
Show All
- Source
- Cite
- Save
Citations (9)
Abstract B141: Combining the telomerase peptide cancer vaccine UV1 with CTLA-4 blockade in patients with metastatic malignant melanoma: Proof of principle and early clinical reports from a phase I/IIa trial

2016 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (0)